Cormorant Asset Management specializes in providing capital solutions to real estate operators, focusing on value-add strategies and opportunistic projects across various property types in the United States. The company offers equity, preferred equity, and mezzanine financing, targeting transactions from $1 million to $100 million, and invests in real estate companies directly.
Recent Transactions involving Cormorant Asset Management
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics |
Spyre Therapeutics |
Aeglea BioTherapeutics |
EcoR1 CapitalFairmount Funds ManagementVenrock Healthcare Capital PartnersCommodore CapitalPerceptive AdvisorsRTW InvestmentsCormorant Asset ManagementDriehaus Capital ManagementSurveyor CapitalWellington Management CompanyUndisclosed Institutional InvestorsFidelity Management and ResearchRA Capital ManagementDeepTrack Capital |
Biotechnology Research |
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →